Tesla Launches Full SelfDriving Supervised in China Amidst Intensifying Local Competition Marvell Dell Earnings and Feds Inflation Gauge Set the Tone for the Trading Week China Emerges as Key Rival in Humanoid Robot Race Tesla CEO Elon Musk Warns Berkshire Hathaway Revives Airline Bet with 26 Billion Stake in Delta Air Lines North American Auto Industry Pins Hopes on New DetroitCanada Bridge to Speed Trade Flows Carvana CVNA Analysts Revise Price Targets Following Stock Split JXN Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds GOOGL Q1 2026 Earnings EPS Misses Estimates as Revenue Uncertainty Weighs on Sentiment PACCAR Q1 2026 Earnings EPS Slightly Misses Estimates Stock Holds Steady Bank7 Corp BSVN Q1 2026 Earnings EPS Surges Past Estimates Strong Performance ICU Q1 2026 Earnings WiderthanExpected Loss as Company Remains PreRevenue CPSS Q4 2025 Earnings EPS Misses Consensus Amidst Challenging Auto Finance Environment Eaton Vance Global Dividend Income Fund ETG Holds Steady as YieldSeekers Maintain Support ProMIS Neurosciences PMN Slips 565 as Shares Test Key Support Level Yatsen Holding YSG Rebounds 386 as Cosmetics Stock Tests Key Resistance Intellicheck IDN Shares Slide 385 as Support Level Nears Critical Test Regentis Biomaterials RGNT Holds Steady at 197 as Bulls Eye Breakout Above 207 Summer Travel Season Fuels Gasoline Demand Pressures QCLS Q4 2017 Earnings Massive EPS Miss Reflects Operational Challenges First Hawaiian Inc FHB Edges Higher as Support Holds Steady LUNR Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent Core Molding Technologies CMT Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines VIV Q1 2026 Earnings EPS Misses Estimates by 2305 as Cost Pressures Weigh Best Buy BBY Q1 2026 Earnings EPS Surprises to the Upside Stock Jumps TFC Q1 2026 Earnings Earnings Beat Signals Resilience in Challenging Rate Environment OTEX Q1 2026 Earnings EPS Surpasses Estimates by 75 Stock Declines Edesa Biotech Inc EDSA Q1 2026 Earnings Wider Than Expected Loss as Clinical Pipeline Progresses